Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 6.52 | N/A |
| PEG Ratio (TTM) | -1.07 | N/A |
| P/S Ratio (TTM) | 0.59 | N/A |
| P/B Ratio (TTM) | 1.55 | N/A |
| P/FCF Ratio (TTM) | 15.41 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.36 | N/A |
| Price to 5YR AVG FCF Ratio | 16.02 | N/A |
Profitability (65%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 12.28% | N/A |
| ROE (TTM) | 25.84% | N/A |
| Net Profit Margin (TTM) | 9.08% | N/A |
| ROIC 5YR AVG | 22.08% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -3.81% | 766.59% | 483.05% |
| Revenue | -1.22% | -6.02% | 2.44% |
| Net Income | -3.96% | 781.06% | 490.33% |
| Cash Flow | 72.71% | 48.08% | 41.82% |
Health (82%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.39 | N/A |
| Quick Ratio (TTM) | 1.16 | N/A |
| D/E Ratio (TTM) | 0.32 | N/A |
| Interest Coverage (TTM) | 9.92 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 4.02 | N/A |
| LTL to 5YR AVG FCF | 3.83 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.17% | N/A |